✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

CG Oncology, Inc.

Common Name
CG Oncology
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
142
Ticker
CGON
Exchange
Nasdaq
Description
CG Oncology Inc. is a clinical biopharmaceutical company focused on bladder cancer, with an emphasis on bladder-sparing therapies for patients with non-muscle invasive disease. The company’s lead prod...

CG Oncology's Revenues Data

Explore CG Oncology's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
4,040,000a
1,139,000a
204,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind CG Oncology’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CG Oncology's 10-K 2025